PHARMAC fully funding innovative improvements in haemophilia treatment

30 April 2019 - PHARMAC has today provided haemophilia patients fully funded access to new innovative treatment options which will ...

Read more →

Decision to make changes to funded haemophilia treatments

8 March 2019 - PHARMAC is pleased to announce changes to funded haemophilia treatments that will result in two new ...

Read more →

Proposal for changes to funded haemophilia treatments

29 January 2019 - PHARMAC is proposing to make changes to the funding of haemophilia treatments from 1 May 2019, ...

Read more →

RFP - supply of recombinant factor VIII, recombinant factor IX and bypassing agents for the treatment of haemophilia

23 July 2018 - PHARMAC invites proposals for the supply of Recombinant Factor VIII, Recombinant Factor IX and bypassing agents (Recombinant ...

Read more →